182 related articles for article (PubMed ID: 6085154)
21. Anticoagulants and thrombolysis in the treatment of pulmonary embolism.
Raskob GE
Curr Opin Pulm Med; 1995 Jul; 1(4):291-7. PubMed ID: 9363067
[TBL] [Abstract][Full Text] [Related]
22. Prolonged acenocoumarol treatment in patients with venous thromboembolic disease from a rural area.
Calvo-Romero JM
South Med J; 2007 Jul; 100(7):725. PubMed ID: 17639755
[No Abstract] [Full Text] [Related]
23. USE OF ANTICOAGULANTS IN THE PREVENTION OF VENOUS THROMBOEMBOLIC DISEASE IN POSTOPERATIVE PATIENTS.
BELDING HH
Arch Surg; 1965 Apr; 90():566-73. PubMed ID: 14267658
[No Abstract] [Full Text] [Related]
24. [Use of heparin and oral anticoagulants to prevent and treat deep venous thrombosis and pulmonary embolism].
Hamerschlak N; Rosenfeld LG
Arq Bras Cardiol; 1996 Sep; 67(3):209-13. PubMed ID: 9181717
[No Abstract] [Full Text] [Related]
25. Long-term therapy of pulmonary embolism.
Agnelli G; Becattini C
Ital Heart J; 2005 Oct; 6(10):824-9. PubMed ID: 16270474
[TBL] [Abstract][Full Text] [Related]
26. Effect of benazepril, a converting enzyme inhibitor, on plasma levels and activity of acenocoumarol and warfarin.
Van Hecken A; De Lepeleire I; Verbesselt R; Arnout J; Angehrn J; Youngberg C; De Schepper PJ
Int J Clin Pharmacol Res; 1988; 8(5):315-9. PubMed ID: 3229872
[TBL] [Abstract][Full Text] [Related]
27. [Current results of hemostasis research (protein C, protein S) and their effect on oral anticoagulant therapy in clinical practice].
Gruber A; Domján G; Blaskó G; Rákóczi I; Petö I; Sas G
Orv Hetil; 1985 Nov; 126(45):2759-64. PubMed ID: 2933622
[No Abstract] [Full Text] [Related]
28. [Thrombolysis in pulmonary embolism with unstable hemodynamics can be life-saving. Discussed treatment strategy--two cases illustrate the problem].
Söderberg M; Edsberg J
Lakartidningen; 2008 Oct 29-Nov 4; 105(44):3112-4. PubMed ID: 19031977
[No Abstract] [Full Text] [Related]
29. Anticoagulants: the state of the art.
Gallus AS
Aust Fam Physician; 1982 Jan; 11(1):14-22. PubMed ID: 7065989
[TBL] [Abstract][Full Text] [Related]
30. Treatment of established deep vein thrombosis: a review of the therapeutic armamentarium.
Berkowitz SD
Orthopedics; 1995 Jul; 18 Suppl():18-20. PubMed ID: 7479421
[TBL] [Abstract][Full Text] [Related]
31. [Evaluation of our manual for prevention of perioperative pulmonary embolism].
Mitsunari H; Nomura Y; Ashikari E; Ebina Y; Nomura M; Ozaki M
Masui; 2005 Jan; 54(1):67-72. PubMed ID: 15717473
[TBL] [Abstract][Full Text] [Related]
32. Prevention of thrombosis during pregnancy.
Vilela VS; de Jesús NR; Levy RA
Isr Med Assoc J; 2002 Oct; 4(10):794-7. PubMed ID: 12389343
[No Abstract] [Full Text] [Related]
33. [Medical treatment of pulmonary thromboembolism].
Nagata H
Nihon Kyobu Shikkan Gakkai Zasshi; 1988 May; 26(5):478-86. PubMed ID: 3225971
[No Abstract] [Full Text] [Related]
34. Heparin in the treatment of pulmonary thromboembolism.
Kanis JA
Thromb Diath Haemorrh; 1974 Dec; 32(2-3):519-27. PubMed ID: 4450203
[No Abstract] [Full Text] [Related]
35. [Case of postoperative pulmonary embolism after tonsillectomy in a healthy young woman].
Igarashi A; Amagasa S; Yokoo N
Masui; 2007 Sep; 56(9):1085-7. PubMed ID: 17877053
[TBL] [Abstract][Full Text] [Related]
36. Effects of heparin therapy on fibrinolysis in patients with pulmonary embolism.
Minnema MC; ten Cate H; van Beek EJ; van den Ende A; Hack CE; Brandjes DP
Thromb Haemost; 1997 Jun; 77(6):1164-7. PubMed ID: 9241751
[TBL] [Abstract][Full Text] [Related]
37. An unexpected case of recurrence of pulmonary embolism in a patient recovered from COVID19 in full regimen dose of direct oral anticoagulant drug.
D'Elia E; Gori M; Grosu A; Iorio A; Lorini FL; Falanga A; Di Marco F; Senni M
BMC Pulm Med; 2021 Mar; 21(1):102. PubMed ID: 33761886
[TBL] [Abstract][Full Text] [Related]
38. [Anticoagulant and thrombolytic therapy in deep venous thrombosis and pulmonary embolism].
Nielsen HK; Lassen JF; Ravn HB; Husted SE
Ugeskr Laeger; 1995 May; 157(20):2835-40. PubMed ID: 7785097
[TBL] [Abstract][Full Text] [Related]
39. Relationship between international normalized ratio values, vitamin K-dependent clotting factor levels and in vivo prothrombin activation during the early and steady phases of oral anticoagulant treatment.
D'Angelo A; Della Valle P; Crippa L; Fattorini A; Pattarini E; Viganò D'Angelo S
Haematologica; 2002 Oct; 87(10):1074-80. PubMed ID: 12368163
[TBL] [Abstract][Full Text] [Related]
40. Secondary prophylaxis with low molecular weight heparin: the dose?
Horne MK
Thromb Haemost; 2001 Oct; 86(4):1129. PubMed ID: 11686343
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
